Evaluation of level I and II axillary nodes included in the standard breast tangential fields and calculation of the administered dose: Results of a prospective study

被引:58
作者
Aristei, C
Chionne, F
Marsella, AR
Alessandro, M
Rulli, A
Lemmi, A
Perrucci, E
Latini, P
机构
[1] Gen Hosp, Inst Radiotherapy Oncol, Perugia, Italy
[2] Gen Hosp, Inst Diagnost Radiol, Perugia, Italy
[3] Gen Hosp, Dept Med Phys, Perugia, Italy
[4] Gen Hosp, Dept Surg, Perugia, Italy
[5] Univ Perugia, I-06100 Perugia, Italy
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2001年 / 51卷 / 01期
关键词
breast cancer; tangential field radiotherapy; axillary nodes;
D O I
10.1016/S0360-3016(01)01595-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate if Level I and II axillary nodes are included in the standard breast tangential fields, and to calculate the dose administered. Methods and Materials: In 35 patients treated with conservative surgery and axillary dissection, three clips were surgically positioned: one at the beginning of Level I one between Level I and IL and another at the end of Level II. The breast was irradiated with two tangential fields. On simulation films, the volume between the clips was scored as "entirely included" or "not entirely included" in the treatment fields. Computed tomography (CT) scans were performed; CT data were imported into a treatment planning system, and three-dimensional plans were devised. Axillary Levels I and II were delineated on CT slices on the basis of anatomic landmarks. Fields and isodose curves previously obtained were superimposed to calculate the dose administered to the first two axillary node levels and to 90% of both volumes. Results: On X-rays, the volume between clips corresponding to Level I was completely included in the medial field in 66.7% of cases and in the lateral field in 63.7% of cases, whereas the volume of Level II was entirely included in the medial field in 54.5% of cases and in the lateral field in 45.4% of cases. The median dose administered to Level I and II was 38.58 Gy +/- 11.01 (range 3.46-47.14) and 20.65 Gy +/- 14.07 (range 0.95-38.94), respectively. The median dose to 90% of both volumes of Level I and II was 6.75 Gy +/- 14.01 (range 1.9-39) and 1.75 Gy +/- 9.72 (range 0.8-29), respectively. Conclusion: The standard tangential fields do not entirely include Levels I and II axillary nodes. (C) 2001 Elsevier Science Inc.
引用
收藏
页码:69 / 73
页数:5
相关论文
共 10 条
[1]  
Botnick M, 1998, INT J RADIAT ONCOL, V42, P245
[2]   Is it possible to treat the axillary nodes in the same radiation fields covering the breast? A study to locate the limits of the axillary dissection relative to anatomic landmarks in the tangential fields [J].
Kiel, KD ;
Chang, S ;
Small, W ;
Bethke, K .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02) :264-264
[3]  
LICHTER AS, 1998, TXB RAD ONCOLOGY, P1013
[4]  
MCNEESE MD, 1992, LEVITT TAPLEYS TECHN, P232
[5]  
OSBORNE MP, 1996, DIS BREAST, P1
[6]  
Pearson E, 1966, Biometrika Tables for Statisticians, V1
[7]  
PEREZ CA, 1997, PRINCIPLES PRACTICE, P1269
[8]   Postmastectomy radiotherapy: Questions for the twenty-first century [J].
Recht, A ;
Bartelink, H ;
Fourquet, A ;
Fowble, B ;
Harris, JR ;
Kurtz, J ;
McCormick, B ;
Olivotto, IA ;
Rutqvist, L ;
Solin, LJ ;
Yarnold, J .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2886-2889
[9]   The modified tangential irradiation technique for breast cancer: How to cover the entire axillary region [J].
Takeda, A ;
Shigematsu, N ;
Kondo, M ;
Amemiya, A ;
Kawaguchi, O ;
Sato, M ;
Kutsuki, S ;
Toya, K ;
Ishibashi, R ;
Kawase, T ;
Tsukamoto, N ;
Kubo, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (04) :815-822
[10]   Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodes [J].
Wong, JS ;
Recht, A ;
Beard, CJ ;
Busse, PM ;
Cady, B ;
Chaffey, JT ;
Come, S ;
Fam, S ;
Kaelin, C ;
Lingos, TI ;
Nixon, AJ ;
Shulman, LN ;
Troyan, S ;
Silver, B ;
Harris, JR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (04) :915-920